6 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in CVD and CKD ... HF outcomes in HFrEF ... on GDMT, with or ... HF outcomes in HFrEF ... #inhibitors #EBM
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
) in HFrEF and CKD ... diuretics, MRA, SGLT2i ... therapies" for HFrEF ... used in HFrEF: ... #CKD #HFrEF #management
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
inhibitor; AF, atrial ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... ACCAHA #Algorithm #Management
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Iron Deficiency ... functional ID) Treatment ... mortality and CV ... deficiency #CHF #HFrEF ... heartfailure #diagnosis #management
TOPCAT - Spironolactone for Heart Failure with Preserved Ejection Fraction

N Engl J Med 2014; 370:1383-1392 https://www.nejm.org/doi/10.1056/NEJMoa1313731

CONCLUSIONS:
ejection fraction, treatment ... hospitalization for the management ... Spironolactone #HFpEF ... dCHF #Cardiology #EBM ... VisualAbstract #Trial
Heart Failure with Preserved Ejection Fraction: Management Principles

General Therapeutic Principles:
Reduce the congestive state 
 - Caution
Ejection Fraction: Management ... hypertension, pulmonary ... ineffective) #Management ... #Cardiology #HFpEF ... dCHF #Diastolic #Treatment